Voss Capital’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Hold |
450,000
| – | – | 0.01% | 54 |
|
|
2025
Q1 | $189K | Sell |
450,000
-50,000
| -10% | -$21K | 0.01% | 54 |
|
|
2024
Q4 | $351K | Buy |
+500,000
| New | +$351K | 0.03% | 43 |
|
|
2023
Q4 | – | Sell |
-60,222
| Closed | -$86.7K | – | 43 |
|
|
2023
Q3 | $86.7K | Hold |
60,222
| – | – | 0.01% | 41 |
|
|
2023
Q2 | $110K | Sell |
60,222
-99,751
| -62% | -$183K | 0.01% | 45 |
|
|
2023
Q1 | $317K | Sell |
159,973
-6,930
| -4% | -$13.7K | 0.04% | 38 |
|
|
2022
Q4 | $350K | Sell |
166,903
-52,197
| -24% | -$110K | 0.07% | 39 |
|
|
2022
Q3 | $416K | Sell |
219,100
-90,372
| -29% | -$172K | 0.12% | 37 |
|
|
2022
Q2 | $653K | Buy |
309,472
+283,033
| +1,071% | +$597K | 0.21% | 31 |
|
|
2022
Q1 | $71K | Hold |
26,439
| – | – | 0.02% | 38 |
|
|
2021
Q4 | $167K | Buy |
+26,439
| New | +$167K | 0.05% | 37 |
|